Looking at the depth, I would say sub $.30 is a thing of the past.
I've been watching another biotech called next science, which floated at $1 only a couple of months ago and is now over $4, valued at nearly half a mill now with revenues of only around ~$4M...
Granted they have a very interesting product portfolio and market opportunities to significantly grow revenue but it's a stark reminder of where PIQ could easily be.
Ann: PromarkerD to feature at world's largest diabetes conference, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $49.05M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $175.8K | 590.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 88240 | 4 |
View Market Depth
| Last trade - 15.08pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |